About
About Xiangxue Pharmaceutical Co.,Ltd
Xiangxue Pharmaceutical Co.,Ltd. engages in the research and development, production, and sales of modern Chinese medicine in China. The company provides ban lan gen granules, flu-over liquid, juhong cough-off liquid, and juhong cough-off decoction; chinese herbal, such as huazhou citri grandis, goji berry, chrysanthemum, and rose dried buds; beverages, including king sarsae, asia sarsae, diet sarsae, juice soda, soymilk, coconut juice, and fruit enzyme; and antiviral oral liquids under the Xiangxue brand name. It also provides medical devices, which includes disposable stereoscopic fixation system for brain; medical orthopedic and cosmetic adhesives; medical tumor serosa sealing adhesives; medical anastomotic adhesives; medical aural and encephalic adhesives; medical obturation adhesives; medical adhesives; and endoscopic trocar. The company was founded in 1986 and is based in Guangzhou, China.
Visit company website
5 years, 6 months ago
Xiangxue Pharmaceutical Co.,Ltd is currently in a long term downtrend where the price is trading 10.7% below its 200 day moving average.
From a valuation standpoint, the stock is 84.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.5.
Xiangxue Pharmaceutical Co.,Ltd's total revenue rose by 3.0% to $678M since the same quarter in the previous year.
Its net income has dropped by 81.4% to $7M since the same quarter in the previous year.
Finally, its free cash flow grew by 5.6% to $-110M since the same quarter in the previous year.
Based on the above factors, Xiangxue Pharmaceutical Co.,Ltd gets an overall score of 3/5.